Search

CareDx Inc

Закрыт

СекторЗдравоохранение

49.48 -5.5

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

49.38

Макс.

52.36

Ключевые показатели

By Trading Economics

Доход

108M

111M

Продажи

14M

132M

P/E

Средняя по отрасли

23.399

57.366

Прибыль на акцию

0.17

Рентабельность продаж

83.848

Сотрудники

761

EBITDA

-3.8M

4.3M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

-8.8% downside

Дивиденды

By Acuity

Следующий отчет о доходах

3 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

579M

2.5B

Предыдущая цена открытия

54.98

Предыдущая цена закрытия

49.48

Новостные настроения

By Acuity

50%

50%

126 / 340 Рейтинг в Healthcare

CareDx Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

28 авг. 2026 г., 23:56 UTC

CareDx Inc shares are higher in after-market hours, reflecting a generally strong performance backdrop amid rising market expectations for a potential interest rate hike.

27 авг. 2026 г., 19:51 UTC

Shares of CareDx Inc. are advancing amid unusually high trading volume. Earlier in the session, shares pulled back from a session high.

26 авг. 2026 г., 20:08 UTC

CareDx Inc shares are higher today, regaining momentum after earlier pulling back. The broader market reflects mixed performance amid recent inflation data.

25 авг. 2026 г., 20:07 UTC

CareDx Inc. shares are higher today, reflecting a strong upward move since Monday amid easing Treasury yields that support equities and investor sentiment.

24 авг. 2026 г., 19:26 UTC

Social Media

CareDx Inc shares are lower today, despite social media discussions projecting a price target of $75 by 2027 and expected revenues of $575 million.

21 авг. 2026 г., 23:01 UTC

CareDx Inc shares are higher in after-market trading, reflecting notable activity despite broader market volatility and no specific company news identified.

20 авг. 2026 г., 20:06 UTC

CareDx Inc. shares are higher, recovering from an earlier pullback, amid rising crude oil prices and increased U.S. Treasury yields influencing market dynamics.

19 авг. 2026 г., 23:56 UTC

CareDx Inc shares are higher in after-market hours, remaining above their 20-day moving average. No specific news was identified to explain the movement.

18 авг. 2026 г., 20:04 UTC

CareDx Inc shares are lower today, reflecting broader market trends amid rising U.S. Treasury yields and inflation concerns. The stock remains down since Monday's close.

14 авг. 2026 г., 20:02 UTC

CareDx Inc shares are lower today amid notable volatility. A recent report showed an unexpected drop in U.S. retail sales, impacting broader market sentiment.

12 авг. 2026 г., 19:36 UTC

CareDx Inc. shares are lower today, reflecting a slight decline since Tuesday's close, despite earlier rebounding from a session low.

11 авг. 2026 г., 23:41 UTC

CareDx Inc shares advanced in after-market trading, reflecting notable gains since Tuesday's close. The stock remains well above its 20-day moving average.

10 авг. 2026 г., 23:46 UTC

CareDx Inc shares are higher in after-market hours, trading significantly above their 20-day moving average and near the upper end of their one-month range.

7 авг. 2026 г., 20:06 UTC

CareDx Inc shares are higher today, recovering from an early dip. The stock has gained significantly since Thursday amid a decline in Treasury yields.

5 авг. 2026 г., 19:46 UTC

Shares of CareDx Inc. are lower today amid unusual volatility, reflecting a broader market sentiment influenced by disappointing employment data from ADP.

4 авг. 2026 г., 21:36 UTC

CareDx Inc shares are higher in after-market trading, reflecting a broader U.S. stock rally amid declining crude oil prices easing inflation concerns.

3 авг. 2026 г., 20:02 UTC

News

CareDx Inc shares rise following a rating upgrade to Buy from Craig-Hallum and a new price target of $64, up from $35.

31 июл. 2026 г., 23:06 UTC

News

CareDx shares are lower in after-market hours despite a 52% revenue increase to $132 million and raised full-year guidance to $490 million-$500 million.

30 июл. 2026 г., 23:41 UTC

News

CareDx Inc reported second-quarter revenue of $132 million, exceeding estimates. Following strong results and raised guidance, shares are higher in after-market trading.

29 июл. 2026 г., 19:56 UTC

CareDx Inc shares are lower, continuing a six-session decline amid rising crude oil prices and inflation concerns affecting broader market sentiment.

27 июл. 2026 г., 19:16 UTC

News

CareDx Inc is trading lower today, reflecting broader market trends amid declining oil prices and easing geopolitical tensions ahead of the Federal Reserve meeting.

22 июл. 2026 г., 19:16 UTC

CareDx Inc shares are lower today with no specific news identified. Broader market sentiment is affected by rising crude oil prices amid geopolitical tensions.

20 июл. 2026 г., 18:53 UTC

News

CareDx shares are lower as Director Valantine Hannah sold 28,779 shares at prices between $36.14 and $36.55, raising investor concerns.

Сравнение c конкурентами

Изменение цены

CareDx Inc Прогноз

Целевая цена

By TipRanks

-8.8% падение

Прогноз на 12 месяцев

Средняя 47.75 USD  -8.8%

Максимум 64 USD

Минимум 21 USD

Основано на мнении 5 аналитиков Wall Street, спрогнозировавших целевые цены для CareDx Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

5 ratings

2

Покупка

3

Удержание

0

Продажа

Настроения

By Acuity

126 / 340Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
help-icon Live chat